Full Professor in physical chemistry of drugs, Faculty of Health of Université Paris Cité (since 2021)
Accreditation to supervise research, i.e., HDR, hab. (2013)
Associate Professor in physical chemistry of drugs, Faculty of Health of the Université Paris Cité (2008 – 2021)
Post-doctorate :Warsaw University – Université de Lorraine – Total Pau – IFP énergies nouvelles Rueil-Malmaison (2005-2008)
CNRS Engineer Doctor in Physical chemistry, Material sciences and Process
Research themes
Yohann Corvis’ research within the Inserm/CNRS/UPCité Chemical and Biological Techniques for Health (UTCBS) Group focuses on formulating nanomedicines based on anticancer drugs, local anesthetics, and anti-inflammatories for targeted therapies and prolonged delivery of the active substance. He conceptualizes, develops, and evaluates the drugs in a biological environment using experimental platforms ranging from pre-formulation to in vivo animal evaluations.
Scientific production
57 publications, 2 journal covers, 3 international patents, 2 technical articles, 1 book chapter and 1 book review. Extensive list of publications here.
33 invited lectures
33 oral and 47 poster presentations (international conferences)
14 oral and 28 poster presentations (national conferences)
Training through research
4 PhD supervised: B. Martin (2016-2019), P. Ma (2019-2023), F. Oyoun (2021-2024), and L. Castillo (2023-2026)
3 PharmD thesis supervised: I. Lim (2022-2023), and A. Kadouci (2023-2024), P. Begon de la Rouzière (2024-2025)
68 internships supervised: students in Pharmacy, Engineering School, Master 2, Master 1, Licence 3, BTS, DUT
Board of Faculty
External member of the Board of Faculty of Health Sciences, Iqra University North campus, Karachi, Pakistan (since 2023)
Commission
Member of the D1Teaching Department (Chemistry and physico-chemistry of drugs) Directors board of the School of Pharmacy, Rank A representative (since 2024)
Member of the HDR (Accreditation to supervise research) Commission of the Faculty of Health of Université Paris Cité (since 2023)
Scientific expertise
Foreign expert for PhD thesis evaluation from the School of Pharmacy of the University of Sindh, Pakistan (since 2023)
External member of the “Conseil Scientifique Inter Régional Grand-Ouest de La Ligue contre le cancer” (2022)
Scientific expert for HTL Biotechnology company (since 2022)
Expert for the French National Agency for Medicine and Health Product Safety (ANSM), in the frame of the Pharmacopoeia French Committee “Fourmulations of chemical, pharmaceutical and radiopharmaceutical substances” (since 2021)
Scientific expert for the compagny Septodont (2016)
Learned societies
Elected board member of SFNano, the French Society for Nanomedicine (since 2021)
Elected board member and Treasurer of AECCPCM, the Society of the teachers and researchers of physical chemistry in Pharmacy (since 2013 and 2024, respectively)
PhD reviewer
2024: E. H. Abad, Université de Bourgogne Franche-Comté | S. El Masri, Université du Littoral Côte d’Opale | Y. Wu, Université Paris-Saclay
2023: G. Khalaf, Université Paris-Saclay | M. Sicot, Université d’Angers | M. Garnier, Sorbonne Université
2021: M. Baroud, Université d’Angers | M. Rakatoarisoa, Université Paris-Saclay
2020: R. Prasad, Indian Institute of Technology, Gandhinagar, India
2016: W. Li, CentraleSupélec, Université Paris-Saclay
2014: B. Clair, CentraleSupélec, Université Paris-Saclay
2013: S. M. H. Sajjadi, Université de Lorraine
PhD examiner
2023: A. Libánská, University of Chemistry and Technology, Prague
Member of Thesis Monitoring Committees (CSI)
2023-2026: E. Chevé, Université Paris Cité